BioTools Innovator
Los Angeles, United States38
6K
37
22
0.03
- Areas of investment
Investor highlights
- Stage focus
- Geo focus
- Check size
- Up to 300K
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 38
- Lead investments
- 22
- Follow on index
- 0.03
- Investments by industry
- Biotechnology (32)
- Manufacturing (8)
- Life Science (7)
- Medical (6)
- Pharmaceutical (5) Show 21 more
- Investments by region
- Switzerland (2)
- United States (28)
- Canada (1)
- Germany (2)
- Spain (1) Show 2 more
- Peak activity year
- 2023
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 4
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| T-Therapeutics | Nov 14, 2025 | Autoimmune disease, Autoimmune Disease, Autoimmune diseases, Biopharmaceutical drug development, Biotechnology, Cancer, Machine-learning, Mouse genome engineering, Single cell genomics, Structural biology, T cell receptor therapeutics, TCR therapeutics | Unknown | 32000000 USD |  Cambridge, England |
| Trimtech Therapeutics | Mar 5, 2025 | Biotech, CNS Penetrant Therapeutics, Neurodegenerative Diseases, Targeted Protein Degradation | Early stage | 31000000 USD | Cambridge, England |
| Cambridge GaN Devices | Feb 18, 2025 | Data Centres, Electric Vehicles, Energy-efficient semiconductors, Semiconductor | - | 32000000 USD | Cambridge, |
| Loyal | Jul 22, 2024 | AI, Consumer Experience Platform, Healthcare Technology | Mid stage | 33500000 USD | Atlanta, Georgia |
| pumpspotting | Jun 9, 2023 | Baby-feeding support, Breastfeeding and pumping support, Breastfeeding support platform, Lactation programs, Tech-enabled program | Early stage | 2200000 USD | Kittery, Maine |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.